2Shen ZY,Shen J,Cai WJ,et at. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells [ J ]. Int J Mol Med,2000,5(2) :155-1582.
3Scholz C, Richer A, Lehmann M, et al. Arsenic trioxide induces regulated,death receptor-independent cell death through a controlled pathway [ J ]. Oncogene ,2005,24:7031-7042.
4Korper S, Nolte F, Thiel E, et al. The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines[ J ]. Br J Haematol , 2004,124 : 186-189.
5Cheung WM, Chu PW, Kwong YL. Effcts of arsenic trioxide on the cellular prolfferation, apoptosis and differentiation of human neuroblastoma cells[ J ]. Cancer Lett,2007,246 : 122-128.
6then Z, Chen GQ,Shen ZX,et M. Expanding the use of arsenic trioxide:leukemias and beyond[J]. Serain Hematol,2002,39 (2 Suppl 1 ) :22-26.
7Porosnicu M,Nimm R,Nguyen D,et al. Co-treatment with As203 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells [ J ]. Leulcemia ,2001,15:772-778.
8Yin T,Wu YL,Sun HP ,et al. Combined effects of As4S4 and imatinib on chronic mydoid leukemia ceils and BCR-ABL oncoprotein [ J ], Blood, 2004, 104: 4219-4225.
9Li JM,Wang AH ,Sun HP,et al. Phase I Clinical trial of Glivec in combination with tetra-arsenlc tetra-sulfide in the treatment of CML patients in advanced phase [ J ]. Blood,2004 ,104 :4653 a.
